Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Simple model systems: a challenge for Alzheimer''s disease.
Di Carlo M
.
???displayArticle.abstract???
The success of biomedical researches has led to improvement in human health and increased life expectancy. An unexpected consequence has been an increase of age-related diseases and, in particular, neurodegenerative diseases. These disorders are generally late onset and exhibit complex pathologies including memory loss, cognitive defects, movement disorders and death. Here, it is described as the use of simple animal models such as worms, fishes, flies, Ascidians and sea urchins, have facilitated the understanding of several biochemical mechanisms underlying Alzheimer''s disease (AD), one of the most diffuse neurodegenerative pathologies. The discovery of specific genes and proteins associated with AD, and the development of new technologies for the production of transgenic animals, has helped researchers to overcome the lack of natural models. Moreover, simple model systems of AD have been utilized to obtain key information for evaluating potential therapeutic interventions and for testing efficacy of putative neuroprotective compounds.
Figure 1. The two pathological hallmarks of AD are extracellular plaques and intracellular tangles. Plaques are formed mostly from the deposition of amyloid beta (Ab) a peptide derived from amyloid precursor protein (APP). The metabolic processing of APP that results in Ab formation requires two enzymatic cleavage events, a b-secretase cleavage by the aspartyl protease beta-site APP-cleaving enzyme (BACE) and a g-secretase cleavage dependent on presenilin. Single beta-amyloid peptides, after misfolding, can aggregate and form fibrils and successively plaques. Filamentous neurofibrillary tangles (NTF) are formed from paired helical filaments composed of hyperphosphorylated tau protein, a microtubule-associated protein.
Figure 2. Simple model systems as zebrafish, Drosophila, C. elegans, Ascidian and sea urchin have been used to study neurodegeneration.
Agnello,
Apoptosis: Focus on sea urchin development.
2010, Pubmed,
Echinobase
Agnello,
Apoptosis: Focus on sea urchin development.
2010,
Pubmed
,
Echinobase
Bai,
Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons.
2006,
Pubmed
Braak,
Neuropathological stageing of Alzheimer-related changes.
1991,
Pubmed
Brand,
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.
1993,
Pubmed
Brösamle,
Characterization of myelination in the developing zebrafish.
2002,
Pubmed
Buznikov,
Sea urchin embryonic development provides a model for evaluating therapies against beta-amyloid toxicity.
2008,
Pubmed
,
Echinobase
Buznikov,
Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids.
2008,
Pubmed
,
Echinobase
Carrotta,
Toxicity of recombinant beta-amyloid prefibrillar oligomers on the morphogenesis of the sea urchin Paracentrotus lividus.
2006,
Pubmed
,
Echinobase
Celotto,
Drosophila: a "model" model system to study neurodegeneration.
2005,
Pubmed
Chen,
Complex splicing and neural expression of duplicated tau genes in zebrafish embryos.
2009,
Pubmed
Crowther,
Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
2005,
Pubmed
Daigle,
apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor.
1993,
Pubmed
Dehal,
The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins.
2002,
Pubmed
Delsuc,
Tunicates and not cephalochordates are the closest living relatives of vertebrates.
2006,
Pubmed
,
Echinobase
Dorsky,
Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway.
2000,
Pubmed
Dosanjh,
Behavioral phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-beta.
2010,
Pubmed
Eriksen,
Plaques, tangles, and memory loss in mouse models of neurodegeneration.
2007,
Pubmed
Fay,
In vivo aggregation of beta-amyloid peptide variants.
1998,
Pubmed
Feany,
A Drosophila model of Parkinson's disease.
2000,
Pubmed
Finelli,
A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster.
2004,
Pubmed
Goedert,
Mutations causing neurodegenerative tauopathies.
2005,
Pubmed
Gong,
Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
2003,
Pubmed
Greeve,
Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila.
2004,
Pubmed
Guntern,
An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease.
1992,
Pubmed
Götz,
Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
2004,
Pubmed
Hardy,
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
2002,
Pubmed
Iijima,
Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila.
2008,
Pubmed
Iijima,
Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.
2004,
Pubmed
Imai,
Neurons of the ascidian larval nervous system in Ciona intestinalis: II. Peripheral nervous system.
2007,
Pubmed
Jackson,
Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila.
2002,
Pubmed
Jackson,
Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.
1998,
Pubmed
Jeibmann,
Drosophila melanogaster as a model organism of brain diseases.
2009,
Pubmed
KIDD,
Paired helical filaments in electron microscopy of Alzheimer's disease.
1963,
Pubmed
Kawai,
Three-dimensional distribution of astrocytes in zebrafish spinal cord.
2001,
Pubmed
Koulen,
Conservation of localization patterns of IP(3) receptor type 1 in cerebellar Purkinje cells across vertebrate species.
2000,
Pubmed
Lee,
Neurodegenerative tauopathies.
2001,
Pubmed
Leimer,
Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis.
1999,
Pubmed
Lessing,
Maintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants.
2009,
Pubmed
Link,
C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
2006,
Pubmed
Link,
Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34.
2001,
Pubmed
Link,
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
1995,
Pubmed
Ma,
Catecholaminergic systems in the zebrafish. IV. Organization and projection pattern of dopaminergic neurons in the diencephalon.
2003,
Pubmed
Moloney,
Alzheimer's disease: insights from Drosophila melanogaster models.
2010,
Pubmed
Nakajima,
Divergent patterns of neural development in larval echinoids and asteroids.
2004,
Pubmed
,
Echinobase
Newman,
Zebrafish as a tool in Alzheimer's disease research.
2011,
Pubmed
Newman,
A zebrafish melanophore model of amyloid beta toxicity.
2010,
Pubmed
Nuttley,
Serotonin mediates food-odor associative learning in the nematode Caenorhabditiselegans.
2002,
Pubmed
Pellicanò,
The sea urchin embryo: a model to study Alzheimer's beta amyloid induced toxicity.
2009,
Pubmed
,
Echinobase
Picone,
Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures.
2009,
Pubmed
Sager,
Transgenic zebrafish models of neurodegenerative diseases.
2010,
Pubmed
Shulman,
Genetic modifiers of tauopathy in Drosophila.
2003,
Pubmed
Sodergren,
The genome of the sea urchin Strongylocentrotus purpuratus.
2006,
Pubmed
,
Echinobase
Steinkraus,
Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans.
2008,
Pubmed
Stokin,
Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides.
2008,
Pubmed
Styren,
X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
2000,
Pubmed
Sulston,
Post-embryonic cell lineages of the nematode, Caenorhabditis elegans.
1977,
Pubmed
Virata,
Ascidians: an invertebrate chordate model to study Alzheimer's disease pathogenesis.
2010,
Pubmed
Voronina,
Apoptosis in sea urchin oocytes, eggs, and early embryos.
2001,
Pubmed
,
Echinobase
Watts,
Collective dynamics of 'small-world' networks.
1998,
Pubmed
Williams,
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
2008,
Pubmed
Zhang,
Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans.
2005,
Pubmed
